Yayın: Pharmacokinetics of ceftriaxone following single ascending intravenous doses in sheep
| dc.contributor.author | Corum, Duygu Durna | |
| dc.contributor.author | Corum, Orhan | |
| dc.contributor.author | Altan, Feray | |
| dc.contributor.author | Eser Faki, Hatice | |
| dc.contributor.author | Bahcivan, Emre | |
| dc.contributor.author | Er, Ayse | |
| dc.contributor.author | Uney, Kamil | |
| dc.date.accessioned | 2026-01-04T12:26:57Z | |
| dc.date.issued | 2018-12-01 | |
| dc.description.abstract | Abstract The objective of this study was to evaluate the pharmacokinetics of CTX following intravenous administration of ascending doses in sheep. In this study, six clinically healthy Akkaraman sheep (2.4 ± 0.4 years and 50 ± 3 kg of body weight) were used. CTX was administered intravenously to each sheep at 20, 40, and 80 mg/kg doses in a crossover design with a 15-day washout period. Plasma concentrations of CTX were measured using the high-performance liquid chromatography-UV method. Pharmacokinetic parameters were calculated by non-compartmental analysis. CTX was well tolerated following administration at 20, 40, and 80 mg/kg doses. The elimination half-life following administration of 40 and 80 mg/kg doses were significantly longer than that of 20 mg/kg dose (P 0.05). When compared to 20 mg/kg, dose-normalized AUC0–∞ at the 80 mg/kg dose significantly increased (P minimum inhibitory concentration (MIC) of >40% for the treatment of infections caused by bacteria with MIC values ≤2, ≤4, and ≤16 μg/mL, respectively. This information may be helpful in adjusting the dosage regimen, but there is a need for future work. | |
| dc.description.uri | https://doi.org/10.1016/j.smallrumres.2018.07.019 | |
| dc.description.uri | https://dx.doi.org/10.1016/j.smallrumres.2018.07.019 | |
| dc.description.uri | https://avesis.deu.edu.tr/publication/details/c313c3b5-34a8-4efc-b60e-bea1c3fc7aa3/oai | |
| dc.description.uri | https://hdl.handle.net/11468/16048 | |
| dc.description.uri | https://hdl.handle.net/20.500.12395/36840 | |
| dc.identifier.doi | 10.1016/j.smallrumres.2018.07.019 | |
| dc.identifier.endpage | 112 | |
| dc.identifier.issn | 0921-4488 | |
| dc.identifier.openaire | doi_dedup___::e866d27f8532e0258431577013114ad8 | |
| dc.identifier.orcid | 0000-0003-3168-2510 | |
| dc.identifier.orcid | 0000-0002-9017-763x | |
| dc.identifier.orcid | 0000-0002-4415-1738 | |
| dc.identifier.orcid | 0000-0002-8674-4873 | |
| dc.identifier.scopus | 2-s2.0-85050946317 | |
| dc.identifier.startpage | 108 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.12597/37053 | |
| dc.identifier.volume | 169 | |
| dc.identifier.wos | 000454968700018 | |
| dc.language.iso | eng | |
| dc.publisher | Elsevier BV | |
| dc.relation.ispartof | Small Ruminant Research | |
| dc.rights | CLOSED | |
| dc.subject | Sheep | |
| dc.subject | Ceftriaxone | |
| dc.subject | Pharmacokinetics | |
| dc.subject | Ascending Dose | |
| dc.subject | Ascending dose | |
| dc.subject.sdg | 3. Good health | |
| dc.title | Pharmacokinetics of ceftriaxone following single ascending intravenous doses in sheep | |
| dc.type | Article | |
| dspace.entity.type | Publication | |
| local.api.response | {"authors":[{"fullName":"Duygu Durna Corum","name":"Duygu Durna","surname":"Corum","rank":1,"pid":null},{"fullName":"Orhan Corum","name":"Orhan","surname":"Corum","rank":2,"pid":{"id":{"scheme":"orcid","value":"0000-0003-3168-2510"},"provenance":null}},{"fullName":"Feray Altan","name":"Feray","surname":"Altan","rank":3,"pid":{"id":{"scheme":"orcid","value":"0000-0002-9017-763x"},"provenance":null}},{"fullName":"Hatice Eser Faki","name":"Hatice","surname":"Eser Faki","rank":4,"pid":null},{"fullName":"Emre Bahcivan","name":"Emre","surname":"Bahcivan","rank":5,"pid":{"id":{"scheme":"orcid","value":"0000-0002-4415-1738"},"provenance":null}},{"fullName":"Ayse Er","name":"Ayse","surname":"Er","rank":6,"pid":null},{"fullName":"Kamil Uney","name":"Kamil","surname":"Uney","rank":7,"pid":{"id":{"scheme":"orcid","value":"0000-0002-8674-4873"},"provenance":null}}],"openAccessColor":null,"publiclyFunded":false,"type":"publication","language":{"code":"eng","label":"English"},"countries":null,"subjects":[{"subject":{"scheme":"FOS","value":"0301 basic medicine"},"provenance":null},{"subject":{"scheme":"FOS","value":"0403 veterinary science"},"provenance":null},{"subject":{"scheme":"FOS","value":"03 medical and health sciences"},"provenance":null},{"subject":{"scheme":"keyword","value":"Sheep"},"provenance":null},{"subject":{"scheme":"keyword","value":"Ceftriaxone"},"provenance":null},{"subject":{"scheme":"keyword","value":"Pharmacokinetics"},"provenance":null},{"subject":{"scheme":"FOS","value":"04 agricultural and veterinary sciences"},"provenance":null},{"subject":{"scheme":"keyword","value":"Ascending Dose"},"provenance":null},{"subject":{"scheme":"keyword","value":"Ascending dose"},"provenance":null},{"subject":{"scheme":"SDG","value":"3. Good health"},"provenance":null}],"mainTitle":"Pharmacokinetics of ceftriaxone following single ascending intravenous doses in sheep","subTitle":null,"descriptions":["Abstract The objective of this study was to evaluate the pharmacokinetics of CTX following intravenous administration of ascending doses in sheep. In this study, six clinically healthy Akkaraman sheep (2.4 ± 0.4 years and 50 ± 3 kg of body weight) were used. CTX was administered intravenously to each sheep at 20, 40, and 80 mg/kg doses in a crossover design with a 15-day washout period. Plasma concentrations of CTX were measured using the high-performance liquid chromatography-UV method. Pharmacokinetic parameters were calculated by non-compartmental analysis. CTX was well tolerated following administration at 20, 40, and 80 mg/kg doses. The elimination half-life following administration of 40 and 80 mg/kg doses were significantly longer than that of 20 mg/kg dose (P 0.05). When compared to 20 mg/kg, dose-normalized AUC0–∞ at the 80 mg/kg dose significantly increased (P minimum inhibitory concentration (MIC) of >40% for the treatment of infections caused by bacteria with MIC values ≤2, ≤4, and ≤16 μg/mL, respectively. This information may be helpful in adjusting the dosage regimen, but there is a need for future work."],"publicationDate":"2018-12-01","publisher":"Elsevier BV","embargoEndDate":null,"sources":["Crossref"],"formats":null,"contributors":["Selcuk University Institutional Repository"],"coverages":null,"bestAccessRight":{"code":"c_14cb","label":"CLOSED","scheme":"http://vocabularies.coar-repositories.org/documentation/access_rights/"},"container":{"name":"Small Ruminant Research","issnPrinted":"0921-4488","issnOnline":null,"issnLinking":null,"ep":"112","iss":null,"sp":"108","vol":"169","edition":null,"conferencePlace":null,"conferenceDate":null},"documentationUrls":null,"codeRepositoryUrl":null,"programmingLanguage":null,"contactPeople":null,"contactGroups":null,"tools":null,"size":null,"version":null,"geoLocations":null,"id":"doi_dedup___::e866d27f8532e0258431577013114ad8","originalIds":["S0921448818302153","10.1016/j.smallrumres.2018.07.019","50|doiboost____|e866d27f8532e0258431577013114ad8","2884254044","c313c3b5-34a8-4efc-b60e-bea1c3fc7aa3","50|od______2605::7f6440445cc62914e530a7d59ec0d704","oai:acikerisim.dicle.edu.tr:11468/16048","50|od______3346::a2eab5dab5976bb2b15dca70f7348257","50|od______4883::75e4becbd91b6333e2d1d79021f3a9e7","oai:acikerisim.selcuk.edu.tr:20.500.12395/36840"],"pids":[{"scheme":"doi","value":"10.1016/j.smallrumres.2018.07.019"},{"scheme":"handle","value":"11468/16048"},{"scheme":"handle","value":"20.500.12395/36840"}],"dateOfCollection":null,"lastUpdateTimeStamp":null,"indicators":{"citationImpact":{"citationCount":5,"influence":2.7597418e-9,"popularity":5.039346e-9,"impulse":2,"citationClass":"C5","influenceClass":"C5","impulseClass":"C5","popularityClass":"C4"}},"instances":[{"pids":[{"scheme":"doi","value":"10.1016/j.smallrumres.2018.07.019"}],"license":"Elsevier TDM","type":"Article","urls":["https://doi.org/10.1016/j.smallrumres.2018.07.019"],"publicationDate":"2018-12-01","refereed":"peerReviewed"},{"alternateIdentifiers":[{"scheme":"doi","value":"10.1016/j.smallrumres.2018.07.019"},{"scheme":"mag_id","value":"2884254044"}],"type":"Article","urls":["https://dx.doi.org/10.1016/j.smallrumres.2018.07.019"],"refereed":"nonPeerReviewed"},{"alternateIdentifiers":[{"scheme":"doi","value":"10.1016/j.smallrumres.2018.07.019"}],"type":"Article","urls":["https://avesis.deu.edu.tr/publication/details/c313c3b5-34a8-4efc-b60e-bea1c3fc7aa3/oai"],"publicationDate":"2018-12-01","refereed":"nonPeerReviewed"},{"pids":[{"scheme":"handle","value":"11468/16048"}],"alternateIdentifiers":[{"scheme":"doi","value":"10.1016/j.smallrumres.2018.07.019"}],"type":"Article","urls":["https://hdl.handle.net/11468/16048","https://doi.org/10.1016/j.smallrumres.2018.07.019"],"publicationDate":"2024-04-24","refereed":"nonPeerReviewed"},{"pids":[{"scheme":"handle","value":"20.500.12395/36840"}],"alternateIdentifiers":[{"scheme":"doi","value":"10.1016/j.smallrumres.2018.07.019"}],"type":"Article","urls":["https://hdl.handle.net/20.500.12395/36840","https://doi.org/10.1016/j.smallrumres.2018.07.019"],"publicationDate":"2018-01-01","refereed":"nonPeerReviewed"},{"alternateIdentifiers":[{"scheme":"mag_id","value":"2884254044"},{"scheme":"doi","value":"10.1016/j.smallrumres.2018.07.019"}],"type":"Article","urls":["https://dx.doi.org/10.1016/j.smallrumres.2018.07.019"],"refereed":"nonPeerReviewed"}],"isGreen":false,"isInDiamondJournal":false} | |
| local.import.source | OpenAire | |
| local.indexed.at | WOS | |
| local.indexed.at | Scopus |
